IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Klaus Urbahns

USPTO Granted Patents = 18

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:

goldMedal18 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1996-2001

Loading Chart...
18 patents (USPTO):Explore Patents
1. 6194428 - Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system (2001-02-27),
2. 6147087 - Use of 1,2-Bridged 1,4-dihydropyridines as medicaments (2000-11-14),
3. 6121284 - 2,3-bridged 1,4-dihydropyridines, and their use as medicaments (2000-09-19),
4. 6103925 - Dimethyl-substituted cyclohexane diene derivatives (2000-08-15),
5. 5990121 - Use of 1,2-bridged 1,4-dihydropyridines as medicaments (1999-11-23),
6. 5955482 - Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments (1999-09-21),
7. 5942526 - 5-acyl-1,4-dihydropyridines (1999-08-24),
8. 5874462 - Use of substituted 6-amino-4H-pyrans (1999-02-23),
9. 5861394 - Use of N-substituted phenothiazines (1999-01-19),
10. 5760073 - Substituted 4H-pyrans (1998-06-02),
11. 5756515 - Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as (1998-05-26),
12. 5719181 - Use of acyl-substituted aminopyrans (1998-02-17),
13. 5670525 - Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the (1997-09-23),
14. 5665741 - 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of (1997-09-09),
15. 5652264 - Cyclohexadiene derivatives useful in the treatment of depression (1997-07-29),

Title: Klaus Urbahns: Innovator in Medicinal Chemistry

Introduction

Klaus Urbahns is a prominent inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of new treatments for central nervous system disorders. With a total of 18 patents to his name, Urbahns has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Among his latest patents, Urbahns has developed methods for the use of 5-substituted pyridine and hexahydroquinoline-3-carboxylic acid derivatives for treating diseases of the central nervous system. This invention focuses on the production of medicaments aimed at addressing cerebral disorders. Another notable patent involves the use of 1,2-bridged 1,4-dihydropyridines as medicaments. This invention highlights their potential as selective potassium channel modulators, particularly for treating conditions related to the central nervous system.

Career Highlights

Klaus Urbahns has had a distinguished career, working with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work has been instrumental in advancing the understanding and treatment of various neurological conditions. His innovative approaches have garnered attention in the scientific community and have contributed to the development of effective therapeutic options.

Collaborations

Throughout his career, Urbahns has collaborated with notable colleagues, including Hans-Georg Heine and Reilinde Wittka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Klaus Urbahns is a significant contributor to the field of medicinal chemistry, with a focus on developing innovative treatments for central nervous system disorders. His extensive patent portfolio and collaborations with esteemed colleagues underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…